Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Offit

Showing results (261-270 of 429) with videos related to

Pageof 43
Sort By:
European Journal of Human Genetics : EJHG|February 2, 2017
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriersLogan C Walker, Louise Marquart, John F Pearson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 8, 2020
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020Mary B Daly, Robert Pilarski, Matthew B Yurgelun, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2018
Germline <i>SDHA</i> mutations in children and adults with cancerMarianne Dubard Gault, Diana Mandelker, Deborah DeLair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2021
Therapeutic Implications of Germline Testing in Patients With Advanced CancersZsofia K Stadler, Anna Maio, Debyani Chakravarty, et al.
Human Genetics|January 25, 2012
Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestryZhaoming Wang, Hemang Parikh, Jinping Jia, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung CancerSemanti Mukherjee, Chaitanya Bandlamudi, Matthew D Hellmann, et al.
Nature Genetics|October 9, 2007
Network modeling links breast cancer susceptibility and centrosome dysfunctionMiguel Angel Pujana, Jing-Dong J Han, Lea M Starita, et al.
Cancer Discovery|December 24, 2021
Cancer-Causative Mutations Occurring in Early EmbryogenesisFresia Pareja, Ryan N Ptashkin, David N Brown, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2021
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMary B Daly, Tuya Pal, Michael P Berry, et al.
JCO Precision Oncology|July 12, 2021
Prevalence and Characterization of Biallelic and Monoallelic <i>NTHL1</i> and <i>MSH3</i> Variant Carriers From a Pan-Cancer Patient PopulationErin E Salo-Mullen, Anna Maio, Semanti Mukherjee, et al.
Pageof 43

Showing results (261-270 of 429) with videos related to

Sort By:
Pageof 43
European Journal of Human Genetics : EJHG|February 2, 2017
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriersLogan C Walker, Louise Marquart, John F Pearson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 8, 2020
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020Mary B Daly, Robert Pilarski, Matthew B Yurgelun, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2018
Germline <i>SDHA</i> mutations in children and adults with cancerMarianne Dubard Gault, Diana Mandelker, Deborah DeLair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2021
Therapeutic Implications of Germline Testing in Patients With Advanced CancersZsofia K Stadler, Anna Maio, Debyani Chakravarty, et al.
Human Genetics|January 25, 2012
Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestryZhaoming Wang, Hemang Parikh, Jinping Jia, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung CancerSemanti Mukherjee, Chaitanya Bandlamudi, Matthew D Hellmann, et al.
Nature Genetics|October 9, 2007
Network modeling links breast cancer susceptibility and centrosome dysfunctionMiguel Angel Pujana, Jing-Dong J Han, Lea M Starita, et al.
Cancer Discovery|December 24, 2021
Cancer-Causative Mutations Occurring in Early EmbryogenesisFresia Pareja, Ryan N Ptashkin, David N Brown, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2021
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMary B Daly, Tuya Pal, Michael P Berry, et al.
JCO Precision Oncology|July 12, 2021
Prevalence and Characterization of Biallelic and Monoallelic <i>NTHL1</i> and <i>MSH3</i> Variant Carriers From a Pan-Cancer Patient PopulationErin E Salo-Mullen, Anna Maio, Semanti Mukherjee, et al.
Pageof 43